CLINICAL_TRIALS
trial_result
· 2014-03-04
Clinical Trial Update: Taste and Palatability of Orfadin Suspension [Phase 1]
Summary
This Phase 1 study evaluated the taste and palatability of Orfadin suspension in patients with hereditary tyrosinemia type I, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Swedish Orphan Biovitrum | Conditions: Hereditary Tyrosinemia, Type I | Phase 1 | Status: COMPLETED | Results posted: 2014-03-04